ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BVS Bioventus Inc

3.97
0.01 (0.25%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 53,010
Bid Price 3.80
Ask Price 5.70
News -
Day High 4.1199

Low
0.86

52 Week Range

High
6.08

Day Low 3.94
Share Name Share Symbol Market Stock Type
Bioventus Inc BVS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.01 0.25% 3.97 19:00:00
Open Price Low Price High Price Close Price Previous Close
4.04 3.94 4.1199 3.97 3.96
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,003 53,010 US$ 4.00 US$ 211,835 - 0.86 - 6.08
Last Trade Type Quantity Price Currency
15:53:19 1 US$ 4.0415 USD

Bioventus Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
315.08M 79.17M - 512.35M -156.23M -1.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bioventus News

Date Time Source News Article
4/29/202406:30GlobeNewswire Inc.Bioventus to Report First Quarter of Fiscal Year 2024..
3/12/202406:30GlobeNewswire Inc.Bioventus Announces Fourth Quarter and Full Year 2023..
3/04/202407:00GlobeNewswire Inc.Bioventus to Report Fourth Quarter of Fiscal Year 2023..
2/06/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202415:07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/19/202407:27Edgar (US Regulatory)Form 8-K - Current report
1/18/202415:15GlobeNewswire Inc.Bioventus Enters into an Amendment with its Credit Agreement..
1/12/202416:10Edgar (US Regulatory)Form 8-K - Current report
1/12/202415:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/12/202415:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
1/12/202415:15GlobeNewswire Inc.Bioventus Announces Inducement Equity to President and Chief..
1/09/202407:55Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BVS Message Board. Create One! See More Posts on BVS Message Board See More Message Board Posts

Historical BVS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.084.293.904.00108,964-0.11-2.70%
1 Month4.935.283.904.50123,134-0.96-19.47%
3 Months4.416.083.904.94144,333-0.44-9.98%
6 Months3.796.083.364.72158,0870.184.75%
1 Year0.996.080.863.26327,7552.98301.01%
3 Years14.4319.94090.79995.27367,657-10.46-72.49%
5 Years15.1019.94090.79995.76360,508-11.13-73.71%

Bioventus Description

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies.

Your Recent History

Delayed Upgrade Clock